Page last updated: 2024-11-01

nifedipine and Precursor Cell Lymphoblastic Leukemia-Lymphoma

nifedipine has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 2 studies

Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.

Precursor Cell Lymphoblastic Leukemia-Lymphoma: A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takahashi, E1
Inanami, O1
Ohta, T1
Matsuda, A1
Kuwabara, M1
Sathiapalan, RK1
El-Solh, H1

Reviews

1 review available for nifedipine and Precursor Cell Lymphoblastic Leukemia-Lymphoma

ArticleYear
Enhanced vincristine neurotoxicity from drug interactions: case report and review of literature.
    Pediatric hematology and oncology, 2001, Volume: 18, Issue:8

    Topics: Child, Preschool; Drug Interactions; Drug Therapy, Combination; Female; Humans; Itraconazole; Neurot

2001

Other Studies

1 other study available for nifedipine and Precursor Cell Lymphoblastic Leukemia-Lymphoma

ArticleYear
Lipid raft disruption prevents apoptosis induced by 2-chloro-2'-deoxyadenosine (Cladribine) in leukemia cell lines.
    Leukemia research, 2006, Volume: 30, Issue:12

    Topics: Apoptosis; beta-Cyclodextrins; Calcium; Cell Line, Tumor; Chelating Agents; Cladribine; Drug Screeni

2006